课题基金 / 基金详情

Rapid-Cycle Survey Collaborative for Provider Input on Immunization Issues: Vaccine Policy Collaborative Initiative

Rapid-Cycle Survey Collaborative for Provider Input on Immunization Issues: Vaccine Policy Collaborative Initiative
快速周期调查合作,以征求提供者对免疫问题的意见:疫苗政策合作倡议
批准号:
9761932
负责人:
ALLISON KEMPE
金额:
$45.0万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-01 至 2020-08-31

项目摘要

项目成果

ALLISON KEMPE的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要/摘要 疫苗接种被公认为20世纪美国最伟大的公共卫生成就之一。 然而,实施新的和现有的疫苗可能会带来巨大的挑战。初级保健 提供者在提供免疫的过程中发挥着核心作用,因此是关键的来源 关于新的或变化的疫苗接种建议的可行性和可接受性的信息。在 目前的应用我们描述了一个多学科的研究团队,拥有迅速 设计、进行和分析对提供者的调查,以应对与免疫有关的问题 交付政策。拟议的研究小组在处理邮件、电子邮件、电话和 混合模式调查和定性方法,如果有必要的话。此外,在之前的四次 项目,研究小组开发了一种进行快速周转的创新方法(在8周内) 使用四个初级保健专科(儿科、普通科)的哨兵提供者网络进行与政策相关的调查 内科、家庭医学和产科/妇科),招聘为相关 每个专业的国家组织。在当前的提案中,我们建议使用此方法来创建 四个初级保健专科的哨兵医生网络,如有需要,还可在其他专科建立哨兵医生网络 公共卫生、药学或护理。我们将每年至少进行三次提供商调查, 应答率,并将计划在每次调查开始后8周内向疾控中心提交初步数据 协议。我们将使用以前成功的流程与疾病预防控制中心合作设计和 完善调查,并建立一个机制,征求两个国家就重要政策问题提出意见 由顾问小组、疫苗交付专家咨询委员会和社区咨询委员会组成。我们 计划通过在ACIP会议上发表演讲来传播我们的调查和定性研究的结果 通过与疾控中心合作者联合出版手稿。研究小组将通力合作 与疾病预防控制中心在当前提案最优先的领域进行合作,包括为建议提供信息 对于新疫苗,提高免疫覆盖率的战略,疫苗融资问题,阻碍 免疫信息系统(IISS)与电子健康记录的接口或提供者对其的使用 为所有年龄段的患者记录疫苗,并制定应急计划以解决紧急问题, 例如疫苗供应短缺、疫苗安全问题或大流行疾病。这些数据将有助于疾控中心 在提出免疫政策建议方面,并将为创建教育和外联活动的努力提供信息 为提供者和患者提供的材料。
英文摘要
Project Summary/Abstract Vaccination has been recognized as one of the greatest U.S. public health achievements of the 20th century. However, implementation of new and established vaccines can pose significant challenges. Primary care providers play a central role in the process of immunization delivery and are, therefore, a critical source of information about the feasibility and acceptability of new or changing vaccination recommendations. In the current application we describe a multidisciplinary study team with the experience and expertise to rapidly design, conduct and analyze surveys of providers in order to respond to issues relevant to immunization delivery policy. The proposed study team has extensive experience in conducting mail, e-mail, telephone and mixed-modality surveys and in qualitative methods, should they be required. In addition, during four previous projects, the study team developed an innovative methodology of conducting rapid turnaround (within 8 weeks) policy-relevant surveys using networks of sentinel providers in four primary care specialties (pediatrics, general internal medicine, family medicine and obstetrics/gynecology), recruited to be representative of the relevant national organization for each specialty. In the current proposal we propose using this methodology to create sentinel physician networks in the four primary care specialties and, if needed, in other specialties including public health, pharmacy or nursing. We will conduct a minimum of three provider surveys per year with high response rates and will plan to have preliminary data to CDC within 8 weeks after initiation of each survey protocol. We will use a previously successful process for collaborating with the CDC in the design and refinement of surveys and a mechanism for eliciting input regarding important policy issues from two national groups of advisors, a vaccine delivery expert advisory committee and a community advisory committee. We plan to disseminate findings of our surveys and qualitative studies through presentations at ACIP meetings and through publications of manuscripts jointly with CDC collaborators. The study team will work collaboratively with the CDC in the areas of highest priority to the current proposal, including input to inform recommendations for new vaccines, strategies to improve immunization coverage, vaccine financing issues, barriers to the interface of immunization information systems (IISs) with electronic health records or their use by providers to document vaccines for patients of all ages, and developing contingency plans to address urgent problems, such as vaccine supply shortages, vaccine safety issues or pandemic disease. Such data will assist the CDC in making immunization policy recommendations and will inform efforts to create educational and outreach materials for providers and patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The HPV9-10 Trial: Early Initiation of HPV Vaccination
  • 批准号:
    10394267
  • 项目类别:
  • 资助金额:
    $63.45万
  • 财政年份:
    2020
  • 负责人:
    ALLISON KEMPE
  • 依托单位:
The HPV9-10 Trial: Early Initiation of HPV Vaccination
  • 批准号:
    10612746
  • 项目类别:
  • 资助金额:
    $63.45万
  • 财政年份:
    2020
  • 负责人:
    ALLISON KEMPE
  • 依托单位:
The HPV9-10 Trial: Early Initiation of HPV Vaccination
  • 批准号:
    10152532
  • 项目类别:
  • 资助金额:
    $65.34万
  • 财政年份:
    2020
  • 负责人:
    ALLISON KEMPE
  • 依托单位:
Rapid-Cycle Survey Collaborative for Provider Input on Immunization Issues: Vaccine Policy Collaborative Initiative
  • 批准号:
    10225280
  • 项目类别:
  • 资助金额:
    $2.23万
  • 财政年份:
    2017
  • 负责人:
    ALLISON KEMPE
  • 依托单位:
国内基金
海外基金
高速Multi-bit/cycle SAR ADC性能优化理论研究
  • 批准号:
    62004023
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    庄浩宇
  • 依托单位:
稀有人参皂苷改善胰岛素抵抗背景下心肌缺血/再灌注损伤的研究——基于Randle cycle调节
  • 批准号:
    81573642
  • 项目类别:
    面上项目
  • 资助金额:
    54.0万元
  • 批准年份:
    2015
  • 负责人:
    刘康
  • 依托单位:
基于Ricci流与Normal Cycle理论的非限制环境下三维人脸识别研究
  • 批准号:
    11401464
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    22.0万元
  • 批准年份:
    2014
  • 负责人:
    李慧斌
  • 依托单位:
动态p-cycle在电网广域系统中的共享风险保护
  • 批准号:
    51307051
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2013
  • 负责人:
    李彬
  • 依托单位: